Hyperbaric oxygenation and Acute kidney injury – Data obtained from experimental studies

7th International Congress of Cardionephrology KARNEF (2025) [pp. 243-247]

AUTHOR(S) / АУТОР(И): Sanjin Kovačević , Nikola Mitovic, Predrag Brkić, Jelena Nesovic Ostojic

Download Full Pdf   

DOI: 10.46793/KARNEF25.253K

ABSTRACT / САЖЕТАК:

Despite constant achievements in treatment, acute kidney injury (AKI) remains a significant public health problem and a cause of mortality in the human population. In developed countries, AKI is a significant and frequent hospital complication, especially among patients admitted to intensive care units, where mortality rates can reach up to 50%. In addition, AKI has been implicated as an independent risk factor for the development of chronic kidney disease. Hyperbaric oxygenation (HBO) has been used as a primary or adjunctive therapy for the past 50 years, both in experimental and clinical studies. HBO is a treatment in which the patient is occasionally exposed to 100% oxygen at a pressure greater than atmospheric pressure at sea level. However, despite decades of extensive research, the entire potentially beneficial effects of this therapeutic protocol are still not fully understood, although many potential mechanisms have been proposed, such as: antioxidative, anti-inflammatory, anti-apoptotic, etc. Furthermore, the low cost and insignificant adverse events make HBO a potentially important strategy in the prevention and treatment of different diseases. Taking all this into account, this paper will present the known effects of HBO on the pathogenesis of AKI obtained from experimental studies.

KEYWORDS / КЉУЧНЕ РЕЧИ:

acute kidney injury, hyperbaric oxygen, experimental studies

REFERENCES / ЛИТЕРАТУРА:

  • Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012; 380(9843):756-766.
  • Makris K, Spanou L. Acute kidney injury: definition, pathophysiology and clinical phenotypes. Clin Biochem Rev 2017;37(2):85–98.
  • Jameson JL, Kasper DL, Longo DL, et al. Harrison’s Principles of Internal Medicine. McGraw-Hill Education, New York, 2020.
  • Hentia C, Rizzato A, Camporesi E, et al. An overview of protective strategies against ischemia/reperfusion injury: The role of hyperbaric oxygen preconditioning. Brain Behav 2018; 8(5):
  • Ortega MA, Fraile-Martinez O, García-Montero C, et al. A General Overview on the Hyperbaric Oxygen Therapy: Applications, Mechanisms and Translational Opportunities. Medicina (Kaunas) 2021; 57(9);
  • Drenjancevic I, Kibel A, Kibel D, et al. Blood pressure, acid-base and blood gas status and indicators of oxidative stress in healthy male rats exposed to acute hyperbaric oxygenation. Undersea Hyperb Med 2013; 40(4):319-328.
  • Lindenmann J, Smolle C, Kamolz LP, et al. Survey of Molecular Mechanisms of Hyperbaric Oxygen in Tissue Repair. Int J Mol Sci 2021; 22(21):
  • Cannellotto M, Garcia AY, Landa Hyperoxia: Effective Mechanism of Hyperbaric Treatment at Mild-Pressure. Int J Mol Sci 2024; 25(2):777.
  • Fu Q, Duan R, Sun Y, et al. Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics. Redox Biol 2022; 53:
  • Schottlender, N.; Gottfried, I.; Ashery, U. Hyperbaric Oxygen Treatment: Effects on Mitochondrial Function and Oxidative Stress. Biomolecules 2021, 11(12), 1827. doi: 10.3390/
  • Berkovitch M, Tsadik R, Kozer E, et al. The effect of hyperbaric oxygen therapy on kidneys in a rat model. Sci World J 2014; 105069.
  • Kovacevic S, Mitovic N, Brkic P, et al. Hyperbaric Oxygenation: Can It Be a Novel Supportive Method in Acute Kidney Injury? Data Obtained from Experimental Studies. Cells 2024;13 (13):1119.
  • Kovacevic S, Ivanov M, Miloradovic Z, et al. Hyperbaric oxygen preconditioning and the role of NADPH oxidase inhibition in postischemic acute kidney injury induced in spontaneously hypertensive rats. PLoS One 2020; 15(1):e0226974.
  • Kovacevic S, Ivanov M, Zivotic M, et al. Immunohistochemical analysis of 4-HNE, NGAL, and HO-1 tissue expression after apocynin treatment and HBO preconditioning in postischemic acute kidney injury induced in spontaneously hypertensive rats. Antioxidants (Basel) 2021; 10(8):1163.
  • Nesovic Ostojic J, Kovacevic S, Ivanov M, et al. Hyperbaric Oxygen Reduces Oxidative Stress Impairment and DNA Damage and Simultaneously Increases HIF-1α in Ischemia–Reperfusion Acute Kidney Injury. Int J Mol Sci 2024;25(7):3870.
  • Nesovic Ostojic J, Ivanov M, Mihailovic-Stanojevic N, et al. Hyperbaric oxygen preconditioning upregulates heme oxygenase-1 and anti-apoptotic bcl-2 protein expression in spontaneously hypertensive rats with induced postischemic acute kidney injury. Int J Mol Sci. 2021; 22(3):1382.
  • Gurer A, Ozdogan M, Gomceli I, et al. Hyperbaric oxygenation attenuates renal ischemia-reperfusion injury in rats. Transplant Proc 2006; 38(10):3337-3340.
  • He X, Xu X, Fan M, et al. Preconditioning with hyperbaric oxygen induces tolerance against renal ischemia-reperfusion injury via increased expression of heme oxygenase. J Surg Res 2011; 170: e271–e277.
  • Ivanov M, Brkic P, Vajic UJ, et al. Hyperbaric oxygenation protects the kidney against ischemia-reperfusion injury. Undersea Hyperb Med 2020;47(1):21-30.
  • Solmazgul E, Uzun G, Cermik H, et al. Hyperbaric oxygen therapy attenuates renal ischemia/ reperfusion injury in rats. Urol Int 2007; 78(1):82–85.
  • Rubinstein I, Abassi Z, Milman F, et al. Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney. Nephrol Dial Transplant 2009; 24(2):428–436.
  • Ramalho RJ, de Oliveira PS, Cavaglieri RC, et al. Hyperbaric oxygen therapy induces kidney protection in an ischemia/reperfusion model in rats. Transplant proc 2012; 44(8): 2333–2336.
  • Ilhan H, Eroglu M, Inal V, et al. Hyperbaric oxygen therapy alleviates oxidative stress and tissue injury in renal ischemia/reperfusion injury in rats. Ren fail 2012; 34(10):1305–1308.
  • Migita H, Yoshitake S, Tange Y, et al. Hyperbaric Oxygen Therapy Suppresses Apoptosis and Promotes Renal Tubular Regeneration After Renal Ischemia/Reperfusion Injury in Rats. Nephrourol mon 2016; 8(1):
  • Ko SF, Chen KH, Wallace CG, et al. Protective effect of combined therapy with hyperbaric oxygen and autologous adipose-derived mesenchymal stem cells on renal function in rodent after acute ischemia-reperfusion injury. Am J Transl Res 2020; 12(7):3272–3287.
  • Atasoyu EM, Yildiz S, Bilgi O, et al. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats. Arch toxicol 2005; 79(5):289–293.
  • Aydinoz S, Uzun G, Cermik H, et al. Effects of different doses of hyperbaric oxygen on cisplatin-induced nephrotoxicity. Ren fail 2007; 29(3): 257–263.
  • Ayvaz S, Aksu B, Kanter M, et al. Preventive effects of hyperbaric oxygen treatment on glycerol-induced myoglobinuric acute renal failure in rats. J mol histol 2012; 43(2):161–170.
  • Ay H, Uzun G, Onem Y, et al. Effect of hyperbaric oxygen on cyclosporine-induced nephrotoxicity and oxidative stress in rats. Ren fail, 2007; 29(4):495-501.
  • Öztopuz Ö, Türkön H, Şehitoğlu, MH, et al. Hyperbaric oxygen treatment ameliorates gentamicin-induced nephrotoxicity and expression of kidney injury molecule 1 in the rat model. Undersea Hyperb Med; 2019:46(2), 125-133.
  • Edremitlioğlu M, Kiliç D, Oter S, et al. The effect of hyperbaric oxygen treatment on the renal functions in septic rats: relation to oxidative damage. Surg today 2005; 35(8):653–661.
  • Sabler IM, Berkovitch M, Sandbank J, et al. Exposure to Hyperbaric Oxygen Intensified Vancomycin-Induced Nephrotoxicity in Rats. PloS one 2016; 11(4):e0152554.
  • Berkovitch M, Shain Y, Kozer E, et al.. Hyperbaric oxygen treatment and nephrotoxicity induced by gentamicin in rats. BMC nephrol 2017; 18(1):
  • Cebi G, Yildiz Ş, Uzun G, et al. The effect of hyperbaric oxygen therapy on rhabdomyolysis-induced myoglobinuric acute renal failure in rats. Ren fail 2016; 38(9):1554–1559.